MX2020006628A - Activador de aldehido deshidrogenasa 2 (aldh2). - Google Patents
Activador de aldehido deshidrogenasa 2 (aldh2).Info
- Publication number
- MX2020006628A MX2020006628A MX2020006628A MX2020006628A MX2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- alkoxy group
- formula
- different
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018015512 | 2018-01-31 | ||
PCT/JP2019/002955 WO2019151241A1 (ja) | 2018-01-31 | 2019-01-29 | Aldh2活性化剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020006628A true MX2020006628A (es) | 2020-09-14 |
Family
ID=67391231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020006628A MX2020006628A (es) | 2018-01-31 | 2019-01-29 | Activador de aldehido deshidrogenasa 2 (aldh2). |
Country Status (12)
Country | Link |
---|---|
US (1) | US10406126B2 (pt) |
EP (1) | EP3747862A1 (pt) |
JP (1) | JPWO2019151241A1 (pt) |
KR (1) | KR20200115474A (pt) |
CN (1) | CN111566082A (pt) |
AU (1) | AU2019214670A1 (pt) |
BR (1) | BR112020014237A2 (pt) |
CA (1) | CA3085992A1 (pt) |
IL (1) | IL275883A (pt) |
MX (1) | MX2020006628A (pt) |
RU (1) | RU2020121490A (pt) |
WO (1) | WO2019151241A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230295091A1 (en) | 2020-11-02 | 2023-09-21 | Alchemedicine, Inc. | Compound, Aldehyde Dehydrogenase 2 Activating Agent, Pharmaceutical Composition, and Therapeutic and/or Prophylactic Drug |
WO2023204292A1 (ja) * | 2022-04-22 | 2023-10-26 | 株式会社アークメディスン | 化合物、アルデヒドデヒドロゲナーゼ2活性化剤、医薬組成物、並びに治療及び/又は予防薬 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1181487A (en) * | 1915-06-21 | 1916-05-02 | Martin Sindell | Portable truck. |
JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
EP2126574B1 (en) * | 2007-03-08 | 2015-12-23 | The Board of Trustees of the Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
JP2012087116A (ja) | 2010-09-21 | 2012-05-10 | Ishihara Sangyo Kaisha Ltd | ベンズアミド誘導体又はその塩、それらを含有する殺虫剤、殺ダニ剤、殺線虫剤又は殺土壌害虫剤 |
US9670162B2 (en) | 2013-03-14 | 2017-06-06 | The Board Of Trustees Of The Leland Stanford Junio | Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof |
US20230295091A1 (en) * | 2020-11-02 | 2023-09-21 | Alchemedicine, Inc. | Compound, Aldehyde Dehydrogenase 2 Activating Agent, Pharmaceutical Composition, and Therapeutic and/or Prophylactic Drug |
-
2019
- 2019-01-29 KR KR1020207017801A patent/KR20200115474A/ko unknown
- 2019-01-29 BR BR112020014237-9A patent/BR112020014237A2/pt not_active Application Discontinuation
- 2019-01-29 JP JP2019569127A patent/JPWO2019151241A1/ja active Pending
- 2019-01-29 RU RU2020121490A patent/RU2020121490A/ru unknown
- 2019-01-29 WO PCT/JP2019/002955 patent/WO2019151241A1/ja active Application Filing
- 2019-01-29 MX MX2020006628A patent/MX2020006628A/es unknown
- 2019-01-29 CN CN201980006700.2A patent/CN111566082A/zh active Pending
- 2019-01-29 CA CA3085992A patent/CA3085992A1/en not_active Abandoned
- 2019-01-29 EP EP19746574.3A patent/EP3747862A1/en not_active Withdrawn
- 2019-01-29 AU AU2019214670A patent/AU2019214670A1/en not_active Abandoned
- 2019-01-29 US US16/260,350 patent/US10406126B2/en not_active Expired - Fee Related
-
2020
- 2020-07-06 IL IL275883A patent/IL275883A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2019151241A1 (ja) | 2019-08-08 |
BR112020014237A2 (pt) | 2020-12-08 |
US20190231720A1 (en) | 2019-08-01 |
CA3085992A1 (en) | 2019-08-08 |
RU2020121490A (ru) | 2022-02-28 |
AU2019214670A1 (en) | 2020-07-09 |
EP3747862A1 (en) | 2020-12-09 |
CN111566082A (zh) | 2020-08-21 |
JPWO2019151241A1 (ja) | 2021-01-28 |
US10406126B2 (en) | 2019-09-10 |
KR20200115474A (ko) | 2020-10-07 |
IL275883A (en) | 2020-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021005714A (es) | Nuevos compuestos heterociclicos. | |
CR20220351A (es) | Inhibidores de proteínas kras mutantes | |
PH12020500236A1 (en) | Heterocyclic compund and use thereof | |
MX2021000795A (es) | Compuestos heterociclicos para inhibir la actividad de shp2. | |
MX2022003401A (es) | Compuesto de piridona fusionada y metodo de preparacion del mismo y uso del mismo. | |
MX2021008241A (es) | Compuesto heterociclico y su uso. | |
MX2020009530A (es) | Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa. | |
UA117151C2 (uk) | N-ациліміногетероциклічні сполуки | |
TW200637539A (en) | CTGF inhibitors | |
CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
MX2009011769A (es) | Derivados de piridona como inhibidores de mapk p38a. | |
CR20220004A (es) | Nuevos compuestos heterocíclicos | |
MX2020001615A (es) | Compuestos de piridina sustituidos con azol. | |
CR20200652A (es) | Compuestos que aumentan la actividad del proteosoma | |
MX2020006628A (es) | Activador de aldehido deshidrogenasa 2 (aldh2). | |
CY1122477T1 (el) | Παραγωγα πυριδο-οξαζινονης ως αναστολεις tnap | |
ZA202101487B (en) | Novel compounds | |
MX2022000944A (es) | Combinaciones, mezclas y composiciones fungicidas y usos de las mismas. | |
PH12019500875A1 (en) | Pyridone compound as c-met inhibitor | |
PH12019500541A1 (en) | Heterocyclic compound, and harmful-arthropod-controlling agent containing same | |
MX2020002505A (es) | Compuestos heteroaromaticos sustituidos con cicloolefinas y su uso. | |
AP2002002466A0 (en) | 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS. | |
MX2021001904A (es) | Formas solidas de benzoxaborol sustituido y composiciones de las mismas. | |
WO2018166993A3 (en) | PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | |
MX2022005201A (es) | Formulaciones de naftalimida dimerica. |